Sagimet Biosciences reported earnings of -$ 0.31 per SGMT share on Nov 12, 2026, beating analysts' expectations by
| Report Date | Nov 12, 2026 |
|---|---|
| Forecasted EPS | -$ 0.26 |
| Earnings Per Share (Surprise) | -$ 0.31 (-$ 0.05) |
| Last Year's EPS | -$ 0.39 |
| EPS YoY Change |
Out of the last 21 earnings reporting periods, Sagimet Biosciences beat analysts’ expectations 10 times and fell short of expectations 4 time(s). Sagimet Biosciences reported earnings per share of -$ 0.31 in the last report falling to reach an estimated EPS of -$ 0.26 by
| Report Date | Forecasted EPS | Reported EPS | Last Year's EPS | EPS YoY Change |
|---|---|---|---|---|
| Nov 12, 2026 | -$ 0.26 | -$ 0.31 | -$ 0.40 | |
| Aug 11, 2026 | -$ 0.25 | -$ 0.26 | -$ 0.32 | |
| May 12, 2026 | -$ 0.39 | -$ 0.33 | -$ 0.56 | |
| Mar 11, 2026 | -$ 0.43 | -$ 0.29 | -$ 0.50 | |
| Nov 13, 2025 | -$ 0.41 | -$ 0.40 | -$ 0.45 | |
| Aug 13, 2025 | -$ 0.52 | -$ 0.32 | -$ 0.25 | |
| May 8, 2025 | -$ 0.79 | -$ 0.56 | -$ 0.23 | |
| Mar 12, 2025 | -$ 0.65 | -$ 0.50 | -$ 0.78 | |
| Nov 14, 2024 | -$ 0.47 | -$ 0.45 | -$ 0.35 | |
| Aug 14, 2024 | -$ 0.34 | -$ 0.25 | -$ 35.80 | |
| May 15, 2024 | -$ 0.41 | -$ 0.23 | -$ 0.30 | |
| Mar 25, 2024 | -$ 0.58 | -$ 0.78 | -$ 0.32 | |
| Nov 13, 2023 | -$ 1.02 | -$ 0.35 | -$ 0.34 | |
| Jul 14, 2023 | -$ 0.50 | -$ 35.80 | -$ 0.32 | |
| Mar 31, 2023 | - | -$ 0.30 | -$ 0.39 | |
| Dec 31, 2022 | - | -$ 0.32 | -$ 0.25 | |
| Sep 30, 2022 | - | -$ 0.34 | -$ 0.18 | |
| Jun 30, 2022 | - | -$ 0.32 | - | - |
| Mar 31, 2022 | - | -$ 0.39 | - | - |
| Mar 31, 2021 | - | -$ 0.25 | - | - |
Sagimet Biosciences’s stock was trading at $ 11.41 on Nov 11, 2026 a day before the last earnings report was released.Following the release of the earnings report, SGMT’s price decreased to $ 10.22 on Nov 13, 2026, recording a
| Report Date | EPS | Price 1 Day Before | Price 1 Day After | Change |
|---|---|---|---|---|
| Nov 12, 2026 | -$ 0.31 | $ 11.41 | $ 10.22 | |
| Aug 11, 2026 | -$ 0.26 | $ 9.57 | $ 9.39 | |
| May 12, 2026 | -$ 0.33 | $ 7.69 | $ 7.60 | |
| Mar 11, 2026 | -$ 0.29 | $ 5.53 | $ 5.34 | |
| Nov 13, 2025 | -$ 0.40 | $ 8.82 | $ 7.75 | |
| Aug 13, 2025 | -$ 0.32 | $ 9.55 | $ 8.67 | |
| May 8, 2025 | -$ 0.56 | $ 3.34 | $ 3.26 | |
| Mar 12, 2025 | -$ 0.50 | $ 3.40 | $ 3.51 | |
| Nov 14, 2024 | -$ 0.45 | $ 6.02 | $ 4.73 | |
| Aug 14, 2024 | -$ 0.25 | $ 2.66 | $ 2.76 | |
| May 15, 2024 | -$ 0.23 | $ 4.38 | $ 4.75 | |
| Mar 25, 2024 | -$ 0.78 | $ 4.51 | $ 5.23 | |
| Nov 13, 2023 | -$ 0.35 | $ 2.59 | $ 2.52 | |
| Jul 14, 2023 | -$ 35.80 | $ 15.95 |
Sagimet Biosciences released its most recent earnings reports in November 2026, August 2026, May 2026, March 2026 respectively. Generally, most companies have a consistent schedule for their earnings releases. However, companies do not necessarily release their earnings reports at the same time each year. The timing of earnings releases can vary depending on a company's fiscal year, industry norms, and internal reporting practices.
Sagimet Biosciences missed analysts’ expectations during the last earnings period by
